Drug Use Investigation of Gadovist.

Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging

NCT00709852 ·Status: COMPLETED ·Phase: PHASE3

Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.

NCT00764387 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)

NCT03986138 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

NCT03996447 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems

NCT05915702 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose

NCT03602339 ·Status: COMPLETED ·Phase: PHASE4

Gadopiclenol vs Gadoxetate MRI for Liver Lesions

NCT06596616 ·Status: ENROLLING_BY_INVITATION

Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children

NCT06010173 ·Status: COMPLETED ·Phase: PHASE3

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

NCT04373564 ·Status: RECRUITING ·Phase: PHASE4

An Observational Study to Collect Information on the Safety of Gadolinium-Based Contrast Agents in Patients in India

NCT06257277 ·Status: COMPLETED

Infiltration of Gadolinium Injection in Brain MR Scans Using Artificial Intelligence

NCT05235646 ·Status: COMPLETED

MR Image Synthesis With Low Gadobutrol Dose and AI

NCT06224543 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

NCT01211873 ·Status: COMPLETED ·Phase: PHASE3

Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis

NCT01326715 ·Status: COMPLETED ·Phase: PHASE1

Comparative Study of Conventional 1.5 and 3.0T MR Images With Synthetically Reconstructed MR Images

NCT02596854 ·Status: COMPLETED ·Phase: NA

In Vitro Study of the Effect of Gadolinium Contrast on Fibrocytes

NCT02512796 ·Status: UNKNOWN

Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI

NCT02395991 ·Status: COMPLETED

Feasibility of Gadolinium Contrast Reduced Brain MRI: the Potential of Deep Learning

NCT06462924 ·Status: WITHDRAWN ·Phase: PHASE1

P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

NCT02633501 ·Status: COMPLETED ·Phase: PHASE2

A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesions

NCT07275814 ·Status: RECRUITING ·Phase: PHASE3

A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions

NCT07275723 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram

NCT00250172 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies

NCT02531360 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI

NCT01812213 ·Status: TERMINATED ·Phase: PHASE2

Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males.

NCT00468806 ·Status: COMPLETED ·Phase: PHASE1